Pfizer Inc And Ors v. Jodas Expoim Pvt Ltd And Anr

CS(COMM) 392/2020

The court framed several issues in this commercial suit concerning alleged patent infringement by the defendants against Pfizer Inc and Ors. The core questions revolve around whether the defendants' activities infringe two specific Indian Patents (No. 218291 and No. 209251) and if the plaintiffs are entitled to permanent injunction or damages.

Jurisdiction
India
Court
Delhi High Court - Orders
Case Number
CS(COMM) 392/2020
Judge(s)
Navin Chawla

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court - Orders. Understanding the court's reasoning in Pfizer Inc And Ors vs Jodas Expoim Pvt Ltd And Anr is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patentCS(COMM) 251/2022

Enlearn Education Private Limited & Anr.vsSd Memorial Education And Welfare Society & Anr.

The Delhi High Court addressed an injunction application filed by Enlearn Education Private Limited against Sd Memorial Education Society concerning the use of the mark 'HERITAGE'. The court found prima facie grounds for intervention, noting that the Defendants adopted a similar name ('THE HERITAGE PRIDE MODERN SCHOOL') after being aware of the Plaintiffs' established trademark rights. Consequently, the Court issued an immediate directive restraining the Defendants from opening any further schools incorporating the word 'HERITAGE' or applying for recognition under that name. The court reserved the final decision on interim relief regarding the existing school until proper notice was served.

patentC.A.(COMM.IPD-PAT) 29/2022

Microsoft Technology Licensing, LLCvsThe Assistant Controller Of Patents And Designs

Microsoft challenged the Assistant Controller's decision rejecting its patent application for a network authentication system under Section 3(k) of the Patent Act, arguing that the invention provided a genuine technical solution to security problems. The Delhi High Court set aside the rejection based on the flawed interpretation of 'computer program per se,' emphasizing that an algorithm should not be automatically excluded if it offers a tangible technical contribution. Consequently, the matter was remanded back to the Controller for re-examination regarding novelty and inventive step.

patentC.S. (Comm. Div.) No.238 of 2024

Apex Laboratories Pvt. Ltd.vsEthichem Biotech

Apex Laboratories Pvt. Ltd filed a suit against Ethichem Biotech and others, alleging infringement of its registered trademarks and copyright related to the product ZINCOVIT. The plaintiff sought permanent injunctions against using deceptively similar marks like ZINCOVITA and for passing off. Despite the initial claims of trademark and copyright violations, the parties ultimately reached an amicable settlement.

patentCS(COMM) 505/2024

Malhotra Surgical IndustriesvsDharam Pal Singh Bhatia & Anr.

In this trademark infringement matter, the Delhi High Court issued interim directions concerning the online sale of 'MICROTONE' products. While the defendant undertook not to sell or distribute the impugned goods, the plaintiff noted that the products remained available on various e-commerce platforms. Consequently, the court directed both parties to file detailed affidavits—the plaintiff detailing current infringing listings and the defendants naming all distributors—to allow for further appropriate judicial action.

patentC.S. (COMM. DIV.) No.130 of 2022

M/S. Kaleesuwari Refinery Private Ltd.vsSri Vinayaka Agro Industries

The Madras High Court ruled in favor of M/S. Kaleesuwari Refinery Private Ltd., granting a permanent injunction against Sri Vinayaka Agro Industries for infringing the registered trade mark 'DHEEPAM' and engaging in passing-off. The court found that the defendant's use of 'V RICH DEEPAM OIL' and its deceptively similar packaging material constituted infringement, despite the defendant failing to appear in court. This judgment reinforces the protection afforded to well-known trademarks against confusingly similar marks.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call